Petter from Romania

Registered at the short selling broker Pepperstone, 2 minutes ago.

» Try Pepperstone you too
78.6% of retail investor accounts lose money when trading spread bets and CFDs with Pepperstone.
Don't show again

Johnson & Johnson (JNJ) shares information

Johnson & Johnson


24h Change

0.28 %

JNJ

Live rate: Market closed

Stock data per Wednesday 14 Apr, 2021

JNJ
NEW YORK STOCK EXCHANGE, INC.
159.48
157.83
159.92
0.44 (+ 0.28%)
US Market is closed

Live Stock price in graph for Johnson & Johnson (JNJ)

  • Latest Volume

    7,718,321 (-58.11 %)

  • Volume prev. day

    18,424,075

  • Avg. daily volume

    7,682,574

  • Market cap

    421,022,434,674

  • P/E ratio

    29.02

  • Today high

    160.1 USD

  • Today low

    157.54 USD

  • 52 week high

    172.57 USD

  • 52 week low

    131.91 USD

  • YTD Change

    + 2.52 %

Quick links

 

Latest news about Johnson & Johnson

Below you can find the most recent news posts about Johnson & Johnson, primarily from US and UK based news sources.

Johnson & Johnson says it continues to believe in the positive benefit-risk profile of its COVID-19 vaccine

Thursday, 15 April 2021, 03:26:04
J&J says it has actively postponed launch of its vaccine in Europe (I posted on the pause in Europe yesterday) By Eamonn Sheridan
— Forexlive


Johnson & Johnson: Continue to believe in positive benefit-risk profile of COVID-19 vaccine

Thursday, 15 April 2021, 03:21:55
“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after th
— FXStreet


The AstraZeneca and J&J vaccines share the same technology. It could explain why both have possible links to rare blood clots.

Thursday, 15 April 2021, 02:27:54
Summary List Placement When coronavirus vaccines were rolled out to the public, regulators knew they would need to watch out for extremely rare reactions. Although clinical trials had shown the shots to be safe among tens of thousands of people, the world was about to vaccinate tens of millions more. Their vigilance paid off earlier this month when European regulators announced that rare blood clots might be an uncommon side effect of AstraZeneca's vaccine. Then on Tuesday, US regulators recommended a pause in the distribution of Johnson & Johnson's vaccine due to six reports of the same type of clot among women who'd received that shot. AstraZeneca's and J&J's vaccines share a platform: Both are viral-vector vaccines , which introduce a coronavirus gene into the body using a genetically engineered common-cold virus, called an adenovirus. Some medical experts are now wondering whether that technology itself could be linked to clotting. “Why are we seeing these few cases for J&J and AstraZeneca?
— Business Insider


Tenn. blood clot patient doesn’t regret getting J&J vaccine

Thursday, 15 April 2021, 01:51:38
A Tennessee woman, who was hospitalized for blood clots after receiving the Johnson & Johnson COVID-19 vaccine, is speaking out about her ordeal. The unidentified patient spoke with several media outlets from her Nashville hospital bed, where she has been unable to walk for a week due to swollen legs and blurred vision. Doctors said…
— New York Post


Johnson & Johnson vaccine use will remain paused in US amid evaluation

Thursday, 15 April 2021, 01:03:10
CDC advisers say they need more evidence to decide if cases of unusual blood clots were linked to the Covid vaccine Johnson & Johnson’s Covid-19 vaccine will remain in limbo a while longer after US health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot – and if so, how big the potential risk really is. The reports are exceedingly rare – six cases out of more than 7m US inoculations with the one-dose vaccine. But the government recommended a pause in Johnson & Johnson vaccinations this week, not long after European regulators declared that such clots are a rare but possible risk with the AstraZeneca vaccine, a shot made in a similar way but not yet approved for use in the US. Continue reading…
— The Guardian


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have JNJ available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.